Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Behav Pharmacol ; 29(8): 745-761, 2018 12.
Article in English | MEDLINE | ID: mdl-30394882

ABSTRACT

The ability to decide advantageously among options that vary in both their risks and rewards is critical for survival and well-being. Previous work shows that some forms of risky decision-making are robustly modulated by monoamine signaling, but it is less clear how monoamine signaling modulates decision-making under risk of explicit punishment. The goal of these experiments was to determine how this form of decision-making is modulated by dopamine, serotonin, and norepinephrine signaling, using a task in which rats choose between a small, 'safe' food reward and a large food reward associated with variable risks of punishment. Preference for the large, risky reward (risk-taking) was reduced by administration of a D2/3 dopamine receptor agonist (bromocriptine) and a selective D2 agonist (sumanirole). The selective D3 agonist PD128907 appeared to attenuate reward discrimination abilities but did not affect risk-taking per se. In contrast, drugs targeting serotonergic and noradrenergic signaling had few if any effects on choice behavior. These data suggest that in contrast to other forms of risky decision-making, decision-making under risk of punishment is selectively modulated by dopamine signaling, predominantly through D2 receptors.


Subject(s)
Biogenic Monoamines/metabolism , Decision Making/physiology , Punishment , Risk-Taking , Adrenergic Uptake Inhibitors/pharmacology , Animals , Atomoxetine Hydrochloride/pharmacology , Conditioning, Operant/drug effects , Conditioning, Operant/physiology , Decision Making/drug effects , Dopamine Agents/pharmacology , Dose-Response Relationship, Drug , Locomotion/drug effects , Male , Models, Animal , Random Allocation , Rats , Rats, Long-Evans , Serotonin Agents/pharmacology
2.
Behav Brain Res ; 321: 130-136, 2017 03 15.
Article in English | MEDLINE | ID: mdl-28057530

ABSTRACT

Chronic administration of cocaine can cause pronounced and enduring cognitive alterations such as increases in impulsive choice. Chronic cocaine can also result in enhanced dopamine (DA) release in the nucleus accumbens (NAc) in response to reward-related cues. It is possible that this enhanced DA release in the NAc is a mechanism by which cocaine increases impulsive choice. To date, however, the specific role of DA in the NAc in impulsive choice is unclear. To begin to address this, rats received acute microinjections of the indirect DA agonist amphetamine directly into the NAc prior to testing in a delay discounting task in which rats chose between a small, immediate and a large, delayed food reward. When delays to the large reward increased within test sessions, amphetamine increased choice of the large reward. When delays decreased within test sessions, however, amphetamine decreased choice of the large reward. These findings suggest that, rather than specifically mediating impulsive choice, DA neurotransmission in the NAc is necessary for flexible adaptation of choice strategies in the presence of shifting reward contingencies. These results further indicate that enhancements in NAc DA release likely do not account for lasting increases in impulsive choice caused by chronic cocaine.


Subject(s)
Amphetamine/pharmacology , Delay Discounting/drug effects , Dopamine Agents/pharmacology , Nucleus Accumbens/drug effects , Analysis of Variance , Animals , Delay Discounting/physiology , Dopamine/metabolism , Dose-Response Relationship, Drug , Impulsive Behavior/drug effects , Impulsive Behavior/physiology , Male , Microinjections , Nucleus Accumbens/metabolism , Psychological Tests , Rats, Long-Evans , Reward
SELECTION OF CITATIONS
SEARCH DETAIL